Gene: AGAP3
Official Full Name: ArfGAP with GTPase domain, ankyrin repeat and PH domain 3provided by HGNC
Gene Summary: This gene encodes an essential component of the N-methyl-D-aspartate (NMDA) receptor signaling complex which mediates long-term potentiation in synapses by linking activation of NMDA receptor to alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor trafficking. The encoded protein contains an N-terminal GTPase-like domain, a pleckstrin homology domain, an ArfGAP domain and several C-terminal ankryn repeat domains. [provided by RefSeq, Apr 2017]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO30463 | AGAP3 Knockout cell line (HeLa) | Human | AGAP3 | 1:3~1:6 | Negative | Online Inquiry |
KO30464 | AGAP3 Knockout cell line (HCT 116) | Human | AGAP3 | 1:2~1:4 | Negative | Online Inquiry |
KO30465 | AGAP3 Knockout cell line (HEK293) | Human | AGAP3 | 1:3~1:6 | Negative | Online Inquiry |
KO30466 | AGAP3 Knockout cell line (A549) | Human | AGAP3 | 1:3~1:4 | Negative | Online Inquiry |
AGAP3 Gene Knockout Cell Lines are genetically engineered cell lines designed to specifically inhibit the expression of the AGAP3 gene, known for its regulatory role in cellular processes such as endocytosis, cell signaling, and proliferation. By utilizing advanced CRISPR/Cas9 technology, these knockout cell lines provide a robust platform for studying the functional implications of AGAP3 in various biological contexts. The mechanism of action involves creating specific double-strand breaks in the AGAP3 gene, leading to insertions or deletions that disrupt the coding sequence, effectively silencing the gene's expression.
The scientific significance of AGAP3 Gene Knockout Cell Lines lies in their potential applications across both research and clinical settings. Researchers studying cancer biology, neurodevelopmental disorders, and cellular signaling pathways can leverage these cell lines to explore how AGAP3 dysregulation contributes to disease states. Furthermore, the versatility of these cell lines allows for the evaluation of pharmacological compounds targeting pathways influenced by AGAP3, paving the way for novel therapeutic strategies.
What sets AGAP3 Gene Knockout Cell Lines apart from conventional models is their specificity and reliability in gene silencing, offering more precise insights into the gene's role. Unlike traditional methods that may have off-target effects or incomplete knockdown, our cell lines guarantee consistent results, thus enhancing the reproducibility of research findings. Additionally, these cell lines are readily available in multiple backgrounds, allowing users to select the most relevant model for their studies.
The valuable insights gained from using AGAP3 Gene Knockout Cell Lines can accelerate the discovery of new biomarkers and treatment options, making them indispensable tools for researchers and clinicians alike. Our commitment to cutting-edge biotechnology and stringent quality controls ensures that our products are of the highest standards, empowering your research and enhancing your capabilities in investigating gene functions and their implications in health and disease.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.